These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8301233)

  • 1. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters.
    Feingold KR; Hardardottir I; Memon R; Krul EJ; Moser AH; Taylor JM; Grunfeld C
    J Lipid Res; 1993 Dec; 34(12):2147-58. PubMed ID: 8301233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordant regulation of proteins of cholesterol metabolism during the acute phase response.
    Feingold KR; Pollock AS; Moser AH; Shigenaga JK; Grunfeld C
    J Lipid Res; 1995 Jul; 36(7):1474-82. PubMed ID: 7595071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cutaneous permeability barrier disruption on HMG-CoA reductase, LDL receptor, and apolipoprotein E mRNA levels in the epidermis of hairless mice.
    Jackson SM; Wood LC; Lauer S; Taylor JM; Cooper AD; Elias PM; Feingold KR
    J Lipid Res; 1992 Sep; 33(9):1307-14. PubMed ID: 1402399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of TNF, IL-1, and the combination of both cytokines on cholesterol metabolism in Syrian hamsters.
    Hardardóttir I; Moser AH; Memon R; Grünfeld C; Feingold KR
    Lymphokine Cytokine Res; 1994 Jun; 13(3):161-6. PubMed ID: 7948424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic HMG-CoA reductase expression and resistance to dietary cholesterol.
    Ness GC; Gertz KR
    Exp Biol Med (Maywood); 2004 May; 229(5):412-6. PubMed ID: 15096653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fatty acids differentially modulate messenger RNA abundance of low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and microsomal triglyceride transfer protein in Golden-Syrian hamsters.
    Dorfman SE; Lichtenstein AH
    Metabolism; 2006 May; 55(5):635-41. PubMed ID: 16631440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors.
    Bisgaier CL; Essenburg AD; Auerbach BJ; Pape ME; Sekerke CS; Gee A; Wölle S; Newton RS
    J Lipid Res; 1997 Dec; 38(12):2502-15. PubMed ID: 9458274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression.
    Ness GC; Lopez D; Chambers CM; Newsome WP; Cornelius P; Long CA; Harwood HJ
    Biochem Pharmacol; 1998 Jul; 56(1):121-9. PubMed ID: 9698096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of hepatic apolipoprotein B, 3-hydroxy-3-methylglutaryl-CoA reductase and low-density lipoprotein receptor mRNA and plasma lipoprotein concentrations by defined dietary fats. Comparison of trimyristin, tripalmitin, tristearin and triolein.
    Bennett AJ; Billett MA; Salter AM; Mangiapane EH; Bruce JS; Anderton KL; Marenah CB; Lawson N; White DA
    Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):167-73. PubMed ID: 7575449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes increases hepatic hydroxymethyl glutaryl coenzyme A reductase protein and mRNA levels in the small intestine.
    Feingold KR; Wilson DE; Wood LC; Kwong LK; Moser AH; Grunfeld C
    Metabolism; 1994 Apr; 43(4):450-4. PubMed ID: 8159102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity.
    Burton PM; Swinney DC; Heller R; Dunlap B; Chiou M; Malonzo E; Haller J; Walker KA; Salari A; Murakami S
    Biochem Pharmacol; 1995 Aug; 50(4):529-44. PubMed ID: 7646560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxin, tumor necrosis factor, and interleukin-1 decrease hepatic squalene synthase activity, protein, and mRNA levels in Syrian hamsters.
    Memon RA; Shechter I; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
    J Lipid Res; 1997 Aug; 38(8):1620-9. PubMed ID: 9300784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diet influences hepatic hydroxymethyl glutaryl coenzyme A reductase and 7alpha-hydroxylase mRNA but not low-density lipoprotein receptor mRNA during development.
    Devlin AM; Innis SM; Shukin R; Rioux MF
    Metabolism; 1998 Jan; 47(1):20-6. PubMed ID: 9440472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of dietary lipids on hepatic mRNA levels of proteins regulating plasma lipoproteins in baboons with high and low levels of large high density lipoproteins.
    Kushwaha RS; McMahan CA; Mott GE; Carey KD; Reardon CA; Getz GS; McGill HC
    J Lipid Res; 1991 Dec; 32(12):1929-40. PubMed ID: 1687745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate restriction and dietary cholesterol modulate the expression of HMG-CoA reductase and the LDL receptor in mononuclear cells from adult men.
    Mutungi G; Torres-Gonzalez M; McGrane MM; Volek JS; Fernandez ML
    Lipids Health Dis; 2007 Nov; 6():34. PubMed ID: 18045475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dietary fats and cholesterol on liver lipid content and hepatic apolipoprotein A-I, B, and E and LDL receptor mRNA levels in cebus monkeys.
    Hennessy LK; Osada J; Ordovas JM; Nicolosi RJ; Stucchi AF; Brousseau ME; Schaefer EJ
    J Lipid Res; 1992 Mar; 33(3):351-60. PubMed ID: 1314879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of genetic variation in genes encoding apolipoprotein A-IV, scavenger receptor BI, HMG-CoA reductase, CETP and apolipoprotein E with cholesterol metabolism and the response to plant stanol ester consumption.
    Plat J; Mensink RP
    Eur J Clin Invest; 2002 Apr; 32(4):242-50. PubMed ID: 11952809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.
    Liang K; Kim CH; Vaziri ND
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F539-44. PubMed ID: 15507547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective compensatory induction of hepatic HMG-CoA reductase in response to inhibition of cholesterol absorption.
    Ness GC; Holland RC; Lopez D
    Exp Biol Med (Maywood); 2006 May; 231(5):559-65. PubMed ID: 16636304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.